APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dolutegravir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dolutegravir Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchDolutegravir Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Dolutegravir Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Dolutegravir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dolutegravir Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dolutegravir Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dolutegravir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dolutegravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dolutegravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dolutegravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dolutegravir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dolutegravir include Shanghai Desano Pharmaceuticals, Mylan, ViiV Healthcare (GSK), LAURUS Labs, Aurobindo Pharma and Adcock Ingram Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dolutegravir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dolutegravir, also provides the sales of main regions and countries. Of the upcoming market potential for Dolutegravir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dolutegravir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dolutegravir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dolutegravir sales, projected growth trends, production technology, application and end-user industry.

Dolutegravir Segment by Company

Shanghai Desano Pharmaceuticals

Mylan

ViiV Healthcare (GSK)

LAURUS Labs

Aurobindo Pharma

Adcock Ingram Limited

Dolutegravir Segment by Type

10mg Tablets

50mg Tablets

Dolutegravir Segment by Application

Prevent HIV Infection Following Potential Exposure

Others

Dolutegravir Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dolutegravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dolutegravir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dolutegravir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dolutegravir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dolutegravir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dolutegravir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dolutegravir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Tablets Major Manufacturers Table 3. 50mg Tablets Major Manufacturers Table 4. Global Dolutegravir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Prevent HIV Infection Following Potential Exposure Major Manufacturers Table 6. Others Major Manufacturers Table 7. Dolutegravir Industry Trends Table 8. Dolutegravir Industry Drivers Table 9. Dolutegravir Industry Opportunities and Challenges Table 10. Dolutegravir Industry Restraints Table 11. Global Dolutegravir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Dolutegravir Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Dolutegravir Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Dolutegravir Revenue Market Share by Region (2021-2026) Table 15. Global Dolutegravir Revenue Market Share by Region (2027-2032) Table 16. Global Dolutegravir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 17. Global Dolutegravir Sales by Region (2021-2026) & (k pcs) Table 18. Global Dolutegravir Sales by Region (2027-2032) & (k pcs) Table 19. Global Dolutegravir Sales Market Share by Region (2021-2026) Table 20. Global Dolutegravir Sales Market Share by Region (2027-2032) Table 21. Global Dolutegravir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Dolutegravir Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Dolutegravir Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dolutegravir Sales Market Share by Manufacturers (2021-2026) Table 25. Global Dolutegravir Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 26. Global Dolutegravir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Dolutegravir Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Dolutegravir Manufacturers, Product Type & Application Table 29. Global Dolutegravir Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Dolutegravir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Dolutegravir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Dolutegravir Revenue Market Share by Type (2021-2026) Table 36. Global Dolutegravir Revenue Market Share by Type (2027-2032) Table 37. Global Dolutegravir Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 38. Global Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 39. Global Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 40. Global Dolutegravir Sales Market Share by Type (2021-2026) Table 41. Global Dolutegravir Sales Market Share by Type (2027-2032) Table 42. Global Dolutegravir Price by Type (2021-2026) & (US$/pcs) Table 43. Global Dolutegravir Price by Type (2027-2032) & (US$/pcs) Table 44. Global Dolutegravir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Dolutegravir Revenue Market Share by Application (2021-2026) Table 48. Global Dolutegravir Revenue Market Share by Application (2027-2032) Table 49. Global Dolutegravir Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 50. Global Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 51. Global Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 52. Global Dolutegravir Sales Market Share by Application (2021-2026) Table 53. Global Dolutegravir Sales Market Share by Application (2027-2032) Table 54. Global Dolutegravir Price by Application (2021-2026) & (US$/pcs) Table 55. Global Dolutegravir Price by Application (2027-2032) & (US$/pcs) Table 56. Shanghai Desano Pharmaceuticals Company Information Table 57. Shanghai Desano Pharmaceuticals Business Overview Table 58. Shanghai Desano Pharmaceuticals Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 59. Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio Table 60. Shanghai Desano Pharmaceuticals Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 64. Mylan Dolutegravir Product Portfolio Table 65. Mylan Recent Development Table 66. ViiV Healthcare (GSK) Company Information Table 67. ViiV Healthcare (GSK) Business Overview Table 68. ViiV Healthcare (GSK) Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 69. ViiV Healthcare (GSK) Dolutegravir Product Portfolio Table 70. ViiV Healthcare (GSK) Recent Development Table 71. LAURUS Labs Company Information Table 72. LAURUS Labs Business Overview Table 73. LAURUS Labs Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. LAURUS Labs Dolutegravir Product Portfolio Table 75. LAURUS Labs Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Dolutegravir Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Adcock Ingram Limited Company Information Table 82. Adcock Ingram Limited Business Overview Table 83. Adcock Ingram Limited Dolutegravir Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Adcock Ingram Limited Dolutegravir Product Portfolio Table 85. Adcock Ingram Limited Recent Development Table 86. North America Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 89. North America Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 90. North America Dolutegravir Sales Price by Type (2021-2026) & (US$/pcs) Table 91. North America Dolutegravir Sales Price by Type (2027-2032) & (US$/pcs) Table 92. North America Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 95. North America Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 96. North America Dolutegravir Sales Price by Application (2021-2026) & (US$/pcs) Table 97. North America Dolutegravir Sales Price by Application (2027-2032) & (US$/pcs) Table 98. North America Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Dolutegravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Dolutegravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Dolutegravir Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 102. North America Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 103. North America Dolutegravir Sales by Country (2027-2032) & (k pcs) Table 104. North America Dolutegravir Sales Price by Country (2021-2026) & (US$/pcs) Table 105. North America Dolutegravir Sales Price by Country (2027-2032) & (US$/pcs) Table 106. United States Dolutegravir Revenue (2021-2032) & (US$ Million) Table 107. Canada Dolutegravir Revenue (2021-2032) & (US$ Million) Table 108. Mexico Dolutegravir Revenue (2021-2032) & (US$ Million) Table 109. Europe Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 112. Europe Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 113. Europe Dolutegravir Sales Price by Type (2021-2026) & (US$/pcs) Table 114. Europe Dolutegravir Sales Price by Type (2027-2032) & (US$/pcs) Table 115. Europe Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 118. Europe Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 119. Europe Dolutegravir Sales Price by Application (2021-2026) & (US$/pcs) Table 120. Europe Dolutegravir Sales Price by Application (2027-2032) & (US$/pcs) Table 121. Europe Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Dolutegravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Dolutegravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Dolutegravir Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 125. Europe Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 126. Europe Dolutegravir Sales by Country (2027-2032) & (k pcs) Table 127. Europe Dolutegravir Sales Price by Country (2021-2026) & (US$/pcs) Table 128. Europe Dolutegravir Sales Price by Country (2027-2032) & (US$/pcs) Table 129. Germany Dolutegravir Revenue (2021-2032) & (US$ Million) Table 130. France Dolutegravir Revenue (2021-2032) & (US$ Million) Table 131. U.K. Dolutegravir Revenue (2021-2032) & (US$ Million) Table 132. Italy Dolutegravir Revenue (2021-2032) & (US$ Million) Table 133. Russia Dolutegravir Revenue (2021-2032) & (US$ Million) Table 134. Spain Dolutegravir Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Dolutegravir Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Dolutegravir Revenue (2021-2032) & (US$ Million) Table 137. Sweden Dolutegravir Revenue (2021-2032) & (US$ Million) Table 138. Poland Dolutegravir Revenue (2021-2032) & (US$ Million) Table 139. China Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 140. China Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 141. China Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 142. China Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 143. China Dolutegravir Sales Price by Type (2021-2026) & (US$/pcs) Table 144. China Dolutegravir Sales Price by Type (2027-2032) & (US$/pcs) Table 145. China Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 146. China Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 147. China Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 148. China Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 149. China Dolutegravir Sales Price by Application (2021-2026) & (US$/pcs) Table 150. China Dolutegravir Sales Price by Application (2027-2032) & (US$/pcs) Table 151. Asia Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 154. Asia Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 155. Asia Dolutegravir Sales Price by Type (2021-2026) & (US$/pcs) Table 156. Asia Dolutegravir Sales Price by Type (2027-2032) & (US$/pcs) Table 157. Asia Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 160. Asia Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 161. Asia Dolutegravir Sales Price by Application (2021-2026) & (US$/pcs) Table 162. Asia Dolutegravir Sales Price by Application (2027-2032) & (US$/pcs) Table 163. Asia Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Dolutegravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Dolutegravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Dolutegravir Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 167. Asia Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 168. Asia Dolutegravir Sales by Country (2027-2032) & (k pcs) Table 169. Asia Dolutegravir Sales Price by Country (2021-2026) & (US$/pcs) Table 170. Asia Dolutegravir Sales Price by Country (2027-2032) & (US$/pcs) Table 171. Japan Dolutegravir Revenue (2021-2032) & (US$ Million) Table 172. South Korea Dolutegravir Revenue (2021-2032) & (US$ Million) Table 173. India Dolutegravir Revenue (2021-2032) & (US$ Million) Table 174. Australia Dolutegravir Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Dolutegravir Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Dolutegravir Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Dolutegravir Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Dolutegravir Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Dolutegravir Sales by Type (2021-2026) & (k pcs) Table 180. SAMEA Dolutegravir Sales by Type (2027-2032) & (k pcs) Table 181. SAMEA Dolutegravir Sales Price by Type (2021-2026) & (US$/pcs) Table 182. SAMEA Dolutegravir Sales Price by Type (2027-2032) & (US$/pcs) Table 183. SAMEA Dolutegravir Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Dolutegravir Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Dolutegravir Sales by Application (2021-2026) & (k pcs) Table 186. SAMEA Dolutegravir Sales by Application (2027-2032) & (k pcs) Table 187. SAMEA Dolutegravir Sales Price by Application (2021-2026) & (US$/pcs) Table 188. SAMEA Dolutegravir Sales Price by Application (2027-2032) & (US$/pcs) Table 189. SAMEA Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Dolutegravir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Dolutegravir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Dolutegravir Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 193. SAMEA Dolutegravir Sales by Country (2021-2026) & (k pcs) Table 194. SAMEA Dolutegravir Sales by Country (2027-2032) & (k pcs) Table 195. SAMEA Dolutegravir Sales Price by Country (2021-2026) & (US$/pcs) Table 196. SAMEA Dolutegravir Sales Price by Country (2027-2032) & (US$/pcs) Table 197. Brazil Dolutegravir Revenue (2021-2032) & (US$ Million) Table 198. Argentina Dolutegravir Revenue (2021-2032) & (US$ Million) Table 199. Chile Dolutegravir Revenue (2021-2032) & (US$ Million) Table 200. Colombia Dolutegravir Revenue (2021-2032) & (US$ Million) Table 201. Peru Dolutegravir Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Dolutegravir Revenue (2021-2032) & (US$ Million) Table 203. Israel Dolutegravir Revenue (2021-2032) & (US$ Million) Table 204. UAE Dolutegravir Revenue (2021-2032) & (US$ Million) Table 205. Turkey Dolutegravir Revenue (2021-2032) & (US$ Million) Table 206. Iran Dolutegravir Revenue (2021-2032) & (US$ Million) Table 207. Egypt Dolutegravir Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Dolutegravir Distributors List Table 211. Dolutegravir Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Dolutegravir Image Figure 2. Global Dolutegravir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dolutegravir Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Tablets Image Figure 5. 50mg Tablets Image Figure 6. Global Dolutegravir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dolutegravir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Prevent HIV Infection Following Potential Exposure Image Figure 9. Others Image Figure 10. Global Dolutegravir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Dolutegravir Revenue (2021-2032) & (US$ Million) Figure 12. Global Dolutegravir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Dolutegravir Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Dolutegravir Revenue Market Share by Region (2021-2032) Figure 15. Global Dolutegravir Sales (2021-2032) & (k pcs) Figure 16. Global Dolutegravir Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 17. Global Dolutegravir Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Dolutegravir Sales YoY (2021-2032) & (k pcs) Figure 19. Europe Dolutegravir Sales YoY (2021-2032) & (k pcs) Figure 20. China Dolutegravir Sales YoY (2021-2032) & (k pcs) Figure 21. Asia (Excluding China) Dolutegravir Sales YoY (2021-2032) & (k pcs) Figure 22. South America, Middle East and Africa Dolutegravir Sales YoY (2021-2032) & (k pcs) Figure 23. Global Dolutegravir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Dolutegravir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Dolutegravir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Dolutegravir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Dolutegravir Revenue Market Share by Type (2021-2032) Figure 29. Global Dolutegravir Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 30. Global Dolutegravir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Dolutegravir Sales Market Share by Type (2021-2032) Figure 32. Global Dolutegravir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Dolutegravir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Dolutegravir Revenue Market Share by Application (2021-2032) Figure 35. Global Dolutegravir Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 36. Global Dolutegravir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Dolutegravir Sales Market Share by Application (2021-2032) Figure 38. North America Dolutegravir Revenue Share by Type (2021-2032) Figure 39. North America Dolutegravir Sales Share by Type (2021-2032) Figure 40. North America Dolutegravir Revenue Share by Application (2021-2032) Figure 41. North America Dolutegravir Sales Share by Application (2021-2032) Figure 42. North America Dolutegravir Revenue Share by Country (2021-2032) Figure 43. North America Dolutegravir Sales Share by Country (2021-2032) Figure 44. Europe Dolutegravir Revenue Share by Type (2021-2032) Figure 45. Europe Dolutegravir Sales Share by Type (2021-2032) Figure 46. Europe Dolutegravir Revenue Share by Application (2021-2032) Figure 47. Europe Dolutegravir Sales Share by Application (2021-2032) Figure 48. Europe Dolutegravir Revenue Share by Country (2021-2032) Figure 49. Europe Dolutegravir Sales Share by Country (2021-2032) Figure 50. China Dolutegravir Revenue Share by Type (2021-2032) Figure 51. China Dolutegravir Sales Share by Type (2021-2032) Figure 52. China Dolutegravir Revenue Share by Application (2021-2032) Figure 53. China Dolutegravir Sales Share by Application (2021-2032) Figure 54. Asia Dolutegravir Revenue Share by Type (2021-2032) Figure 55. Asia Dolutegravir Sales Share by Type (2021-2032) Figure 56. Asia Dolutegravir Revenue Share by Application (2021-2032) Figure 57. Asia Dolutegravir Sales Share by Application (2021-2032) Figure 58. Asia Dolutegravir Revenue Share by Country (2021-2032) Figure 59. Asia Dolutegravir Sales Share by Country (2021-2032) Figure 60. SAMEA Dolutegravir Revenue Share by Type (2021-2032) Figure 61. SAMEA Dolutegravir Sales Share by Type (2021-2032) Figure 62. SAMEA Dolutegravir Revenue Share by Application (2021-2032) Figure 63. SAMEA Dolutegravir Sales Share by Application (2021-2032) Figure 64. SAMEA Dolutegravir Revenue Share by Country (2021-2032) Figure 65. SAMEA Dolutegravir Sales Share by Country (2021-2032) Figure 66. Dolutegravir Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Dolutegravir Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg Tablets
  • 50mg Tablets
Applications
  • Prevent HIV Infection Following Potential Exposure
  • Others
Companies covered
  • Shanghai Desano Pharmaceuticals
  • Mylan
  • ViiV Healthcare (GSK)
  • LAURUS Labs
  • Aurobindo Pharma
  • Adcock Ingram Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dolutegravir Market by Type
  3. 1.2.1 Global Dolutegravir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg Tablets
  5. 1.2.3 50mg Tablets
  6. 1.3 Dolutegravir Market by Application
  7. 1.3.1 Global Dolutegravir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Prevent HIV Infection Following Potential Exposure
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Dolutegravir Market Dynamics
  1. 2.1 Dolutegravir Industry Trends
  2. 2.2 Dolutegravir Industry Drivers
  3. 2.3 Dolutegravir Industry Opportunities and Challenges
  4. 2.4 Dolutegravir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dolutegravir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dolutegravir Revenue by Region
  3. 3.2.1 Global Dolutegravir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dolutegravir Revenue by Region (2021-2026)
  5. 3.2.3 Global Dolutegravir Revenue by Region (2027-2032)
  6. 3.2.4 Global Dolutegravir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dolutegravir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dolutegravir Sales by Region
  9. 3.4.1 Global Dolutegravir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dolutegravir Sales by Region (2021-2026)
  11. 3.4.3 Global Dolutegravir Sales by Region (2027-2032)
  12. 3.4.4 Global Dolutegravir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dolutegravir Revenue by Manufacturers
  2. 4.1.1 Global Dolutegravir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dolutegravir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dolutegravir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dolutegravir Sales by Manufacturers
  6. 4.2.1 Global Dolutegravir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dolutegravir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dolutegravir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dolutegravir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dolutegravir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dolutegravir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dolutegravir Manufacturers, Product Type & Application
  13. 4.7 Global Dolutegravir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dolutegravir Market CR5 and HHI
  16. 4.8.2 2025 Dolutegravir Tier 1, Tier 2, and Tier 3
5 Dolutegravir Market by Type
  1. 5.1 Global Dolutegravir Revenue by Type
  2. 5.1.1 Global Dolutegravir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dolutegravir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dolutegravir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dolutegravir Sales by Type
  6. 5.2.1 Global Dolutegravir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dolutegravir Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Dolutegravir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dolutegravir Price by Type
6 Dolutegravir Market by Application
  1. 6.1 Global Dolutegravir Revenue by Application
  2. 6.1.1 Global Dolutegravir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dolutegravir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dolutegravir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dolutegravir Sales by Application
  6. 6.2.1 Global Dolutegravir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dolutegravir Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Dolutegravir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dolutegravir Price by Application
7 Company Profiles
  1. 7.1 Shanghai Desano Pharmaceuticals
  2. 7.1.1 Shanghai Desano Pharmaceuticals Company Information
  3. 7.1.2 Shanghai Desano Pharmaceuticals Business Overview
  4. 7.1.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolio
  6. 7.1.5 Shanghai Desano Pharmaceuticals Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Dolutegravir Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 ViiV Healthcare (GSK)
  14. 7.3.1 ViiV Healthcare (GSK) Company Information
  15. 7.3.2 ViiV Healthcare (GSK) Business Overview
  16. 7.3.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 ViiV Healthcare (GSK) Dolutegravir Product Portfolio
  18. 7.3.5 ViiV Healthcare (GSK) Recent Developments
  19. 7.4 LAURUS Labs
  20. 7.4.1 LAURUS Labs Company Information
  21. 7.4.2 LAURUS Labs Business Overview
  22. 7.4.3 LAURUS Labs Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 LAURUS Labs Dolutegravir Product Portfolio
  24. 7.4.5 LAURUS Labs Recent Developments
  25. 7.5 Aurobindo Pharma
  26. 7.5.1 Aurobindo Pharma Company Information
  27. 7.5.2 Aurobindo Pharma Business Overview
  28. 7.5.3 Aurobindo Pharma Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Aurobindo Pharma Dolutegravir Product Portfolio
  30. 7.5.5 Aurobindo Pharma Recent Developments
  31. 7.6 Adcock Ingram Limited
  32. 7.6.1 Adcock Ingram Limited Company Information
  33. 7.6.2 Adcock Ingram Limited Business Overview
  34. 7.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Adcock Ingram Limited Dolutegravir Product Portfolio
  36. 7.6.5 Adcock Ingram Limited Recent Developments
8 North America
  1. 8.1 North America Dolutegravir Market Size by Type
  2. 8.1.1 North America Dolutegravir Revenue by Type (2021-2032)
  3. 8.1.2 North America Dolutegravir Sales by Type (2021-2032)
  4. 8.1.3 North America Dolutegravir Price by Type (2021-2032)
  5. 8.2 North America Dolutegravir Market Size by Application
  6. 8.2.1 North America Dolutegravir Revenue by Application (2021-2032)
  7. 8.2.2 North America Dolutegravir Sales by Application (2021-2032)
  8. 8.2.3 North America Dolutegravir Price by Application (2021-2032)
  9. 8.3 North America Dolutegravir Market Size by Country
  10. 8.3.1 North America Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dolutegravir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dolutegravir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dolutegravir Market Size by Type
  2. 9.1.1 Europe Dolutegravir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dolutegravir Sales by Type (2021-2032)
  4. 9.1.3 Europe Dolutegravir Price by Type (2021-2032)
  5. 9.2 Europe Dolutegravir Market Size by Application
  6. 9.2.1 Europe Dolutegravir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dolutegravir Sales by Application (2021-2032)
  8. 9.2.3 Europe Dolutegravir Price by Application (2021-2032)
  9. 9.3 Europe Dolutegravir Market Size by Country
  10. 9.3.1 Europe Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dolutegravir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dolutegravir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dolutegravir Market Size by Type
  2. 10.1.1 China Dolutegravir Revenue by Type (2021-2032)
  3. 10.1.2 China Dolutegravir Sales by Type (2021-2032)
  4. 10.1.3 China Dolutegravir Price by Type (2021-2032)
  5. 10.2 China Dolutegravir Market Size by Application
  6. 10.2.1 China Dolutegravir Revenue by Application (2021-2032)
  7. 10.2.2 China Dolutegravir Sales by Application (2021-2032)
  8. 10.2.3 China Dolutegravir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dolutegravir Market Size by Type
  2. 11.1.1 Asia Dolutegravir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dolutegravir Sales by Type (2021-2032)
  4. 11.1.3 Asia Dolutegravir Price by Type (2021-2032)
  5. 11.2 Asia Dolutegravir Market Size by Application
  6. 11.2.1 Asia Dolutegravir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dolutegravir Sales by Application (2021-2032)
  8. 11.2.3 Asia Dolutegravir Price by Application (2021-2032)
  9. 11.3 Asia Dolutegravir Market Size by Country
  10. 11.3.1 Asia Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dolutegravir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dolutegravir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dolutegravir Market Size by Type
  2. 12.1.1 SAMEA Dolutegravir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dolutegravir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dolutegravir Price by Type (2021-2032)
  5. 12.2 SAMEA Dolutegravir Market Size by Application
  6. 12.2.1 SAMEA Dolutegravir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dolutegravir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dolutegravir Price by Application (2021-2032)
  9. 12.3 SAMEA Dolutegravir Market Size by Country
  10. 12.3.1 SAMEA Dolutegravir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dolutegravir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dolutegravir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dolutegravir Value Chain Analysis
  2. 13.1.1 Dolutegravir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dolutegravir Production Mode & Process
  6. 13.2 Dolutegravir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dolutegravir Distributors
  9. 13.2.3 Dolutegravir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst